ArticleCancer drug resistance (Alhambra, Calif.)2021

Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?

Kyung Bo KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.